Who Qualifies for Medical Weight Loss Treatment? BMI & Health Criteria
Quick Answer: Standard qualification for GLP-1 weight-loss medication: BMI ≥30, or BMI ≥27 with at least one weight-related condition (type 2 diabetes, hypertension, PCOS, fatty liver, sleep apnoea, dyslipidaemia) — with Asian-population guidance often applying lower thresholds given metabolic risk at lower BMIs. Qualification also screens out: pregnancy, specific thyroid-cancer histories, eating-disorder patterns, and normal-weight cosmetic requests. The evaluation appointment — not the internet chart — issues the answer.
The Criteria, Properly Framed
BMI anchors the conversation but doesn't finish it. The Indian-context nuance matters: South Asian populations carry metabolic risk (diabetes, visceral fat) at lower BMIs than Western charts assume — which is why Indian clinical practice often engages the ≥27-with-comorbidity lane earnestly, and why waist circumference and body-composition data share the table with the BMI number. The comorbidity list that activates the lower threshold: type 2 diabetes and pre-diabetes, hypertension, PCOS (the dedicated article next door), diagnosed fatty liver, obstructive sleep apnoea, dyslipidaemia, and weight-loaded joint disease.
What the Evaluation Actually Checks
The qualifying visit runs three screens at once: eligibility (the criteria above, measured not estimated), safety (the who-should-not article's contraindication map — thyroid-cancer family history, pancreatitis, pregnancy plans, medication interactions), and appropriateness (eating-disorder screening, expectation calibration, readiness for the programme's non-medication half). Passing all three opens the prescription conversation; failing any redirects to the right lane instead — which is the system working, not gatekeeping.
The Redirections, Respectfully
Normal-BMI cosmetic requests: the medications' evidence, risks, and approvals live in obesity medicine — "I want to lose 4kg for the reception" gets nutrition support and the honest no (the ethical-refusal doctrine from the aesthetics clusters, metabolic edition). Eating-disorder histories: protective screening, specialist routing — appetite-suppressing medication atop disordered patterns is harm, not help. The almost-qualifying: supervised non-medication programmes exist precisely for the BMI-26-no-comorbidity case — and reassessment stays open.
FAQs
I'm BMI 28 with PCOS — do I qualify? The 27-plus-comorbidity lane fits — evaluation confirms individually.
Can my GP's letter substitute for the clinic evaluation? Records help; the prescribing clinic still runs its own screening — titration and monitoring live there.
Do the thresholds differ for men and women? Same BMI framework; body-composition context differs and the evaluation reads it.
What if I qualified last year but lost weight since? Qualification tracks current status — maintenance-phase support uses different tools than initiation.
Consult Dr Neha Batra at DermaWorld Skin Clinic, Rajouri Garden, New Delhi 📞 Call: 9911100050 | 💬 WhatsApp Us | 📩 Book via Contact Form Clinic: Q-4, Rajouri Garden, New Delhi – 110027 Weight-loss medications are prescription-only and require medical evaluation. This article is educational, not a substitute for consultation.